Keratoconus is a non-inflammatory corneal ectasia that leads to a reduction in visual acuity, often requiring visual rehabilitation with contact lenses.
Objectives
To assess the impact of SPOT® lenses on visual acuity improvement in patients with keratoconus, categorized by their stage according to the Amsler-Krumeich classification, and to analyze the correlation between disease stage and visual gain. Secondary objectives include evaluating visual acuity gain in patients who failed to adapt to the lenses, and in those with one or more corneal opacities.
Methods
This monocentric, retrospective, observational study included keratoconus patients treated at the CHU of Clermont-Ferrand. Patients underwent initial adaptation to SPOT® lenses between June 2017 and June 2024. Exclusion criteria included ophthalmological conditions that could impair visual acuity.
Results
A total of 257 eyes from 150 patients were analyzed. Of these, 193 eyes fitted with SPOT® scleral lenses were included in the primary analysis. The mean best-corrected visual acuity (BCVA) improved from 0.61 ± 0.59 -LogMAR before adaptation to 0.11 ± 0.14 -LogMAR after, with an average gain of 5 lines. Significant differences (p < 0.05) in visual acuity were observed across all stages, except between stages I and II before adaptation, and between stages I and II, and II and III after adaptation. Significant differences (p < 0.05) in visual acuity gain were found between each stage, except between stages I and II.
Conclusion
The success of scleral lens adaptation is closely linked to improved visual acuity, particularly in the more advanced stages of the disease.
ShettyRD’SouzaSKhamarP, et al.Biochemical markers and alterations in keratoconus. Asia-Pac J Ophthalmol2020; 9: 533–540. doi:10.1097/APO.0000000000000332.
6.
AhujaPDadachanjiZShettyR, et al.Relevance of IgE, allergy and eye rubbing in the pathogenesis and management of keratoconus. Indian J Ophthalmol2020; 68: 2067–2074. doi:10.4103/ijo.IJO_1191_19.
7.
DavidsonHayesHardcastle , et al.The pathogenesis of keratoconus. Eyefévr 2014; 28: 189–195. doi:10.1038/eye.2013.278.
8.
Santodomingo-RubidoJCarracedoGSuzakiA, et al.Keratoconus: an updated review. Contact Lens Anterior Eye2022; 45: 101559. doi:10.1016/j.clae.2021.101559.
9.
HaseebAHuynhEElSheikhRH, et al.Down syndrome: a review of ocular manifestations. Ther Adv Ophthalmol2022; 14: 25158414221101718.
10.
LinKKLeeJSHouCH, et al.The sociodemographic and risk factors for keratoconus: nationwide matched case-control study in Taiwan, 1998-2015. Am J Ophthalmol2021; 223: 140–148. doi:10.1016/j.ajo.2020.09.040.
RabinowitzYS. Videokeratographic indices to aid in screening for keratoconus. J Refract Surg1995; 11: 371–379. doi:10.3928/1081-597X-19950901-14.
13.
TouboulDRobinet-PerrinAFourniéP, et al.Efficacité du cross-linking du collagène cornéen pour le traitement du kératocône. J Fr Ophtalmol2016; 39: 308–314. doi:10.1016/j.jfo.2015.12.002.
14.
WollensakGSpoerlESeilerT. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol2003; 135: 620–627. doi:10.1016/S0002-9394(02)02220-1.
15.
SakellarisDBalidisMGorouO, et al.Intracorneal ring segment implantation in the management of keratoconus: an evidence-based approach. Ophthalmol Ther2019; 8: 5–14. doi:10.1007/s40123-019-00211-2.
16.
van der WorpEBarnettMJohnsL. Scleral lenses: history & future. Contact Lens Anterior Eye2018; 41: 243–244. doi:10.1016/j.clae.2018.04.201.
KimKHMianSI. Refractive approaches to visual rehabilitation in patients with keratoconus. Curr Opin Ophthalmol2020; 31: 261–267. doi:10.1097/ICU.0000000000000675.
22.
HeneinCNanavatyMA. Systematic review comparing penetrating keratoplasty and deep anterior lamellar keratoplasty for management of keratoconus. Contact Lens Anterior Eye J Br Contact Lens Assocfévr 2017; 40: 3–14. doi:10.1016/j.clae.2016.10.001.
23.
FoglaR. Deep anterior lamellar keratoplasty in the management of keratoconus. Indian J Ophthalmol2013; 61: 465–468. doi:10.4103/0301-4738.116061.
24.
BézéSBenoist D’azyCLambertC, et al.Efficacy of visual rehabilitation of patients with pellucid marginal degeneration fitted with SPOT® scleral contact lenses. J Fr Ophtalmol2020; 43: e1–e5. doi:10.1016/j.jfo.2019.11.004.
25.
HänischKTNeppertBGeerlingG. Gas permeable scleral lenses as a conservative treatment option for extreme corneal ectasias and severe dry eye. Ophthalmol Z Dtsch Ophthalmol Ges2005; 102: 387–392.
26.
MartyASJurkiewiczTMouchelR, et al.Benefits of scleral Lens in the management of irregular corneas and dry eye syndrome after refractive surgery. Eye Contact Lens2022; 48: 318–321. doi:10.1097/ICL.0000000000000919.
27.
NavelVBarriereJVJoubertR, et al.Irregular astigmatism management using SPOT scleral lenses in the treatment of corneal ectasia and penetrating keratoplasty. Eye Contact Lens2021; 47: 401–407. doi:10.1097/ICL.0000000000000792.
28.
SchornackMNauCNauA, et al.Visual and physiological outcomes of scleral lens wear. Contact Lens Anterior Eye2019; 42: 3–8. doi:10.1016/j.clae.2018.07.007.
PicotCGauthierASCampolmiN, et al.Qualité de vie des patients équipés en verres scléraux. J Fr Ophtalmol2015; 38: 615–619. doi:10.1016/j.jfo.2014.10.018.
31.
MontaltJCPorcarEEspaña-GregoriE, et al.Visual quality with corneo-scleral contact lenses for keratoconus management. Contact Lens Anterior Eye2018; 41: 351–356. doi:10.1016/j.clae.2018.01.002.
32.
KoppenCKrepsEOAnthonissenL, et al.Scleral lenses reduce the need for corneal transplants in severe keratoconus. Am J Ophthalmol2018; 185: 43–47. doi:10.1016/j.ajo.2017.10.022.
33.
ScanzeraACDeeleyMJoslinC, et al. Contact Lens prescribing trends for keratoconus at an academic medical center: increased utilization of scleral lenses for severe disease. Eye Contact Lens2022; 48: 58–62. doi:https://doi.org/10.1097/ICL.0000000000000869.
34.
ZadnikKBarrJTEdringtonTB, et al.Baseline findings in the collaborative longitudinal evaluation of keratoconus (CLEK) study. Invest Ophthalmol Vis Sci1998; 39: 2537–2546.
35.
EdringtonTBSzczotkaLBBarrJT, et al.Rigid contact lens fitting relationships in keratoconus. Collaborative longitudinal evaluation of keratoconus (CLEK) study group. Optom Vis Sci Off Publ Am Acad Optom1999; 76: 692–699. doi:10.1097/00006324-199910000-00020.
